Update on hypertrophic scar treatment

Clinics

Volumn 69, Issue 8, 2014, Pages 565-573

  Rabello, Felipe Bettini ^a   Souza, Cleyton Dias ^a   Farina Jr , Jayme Adriano ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Hypertrophic Scar; Pathological Scars; Review; Update

Indexed keywords

BLEOMYCIN; CORTICOSTEROID; SILICONE GEL;

CICATRIX, HYPERTROPHIC; HUMAN; INTRALESIONAL DRUG ADMINISTRATION; KELOID; MAST SUIT; PATHOLOGY; WOUND HEALING;

ADRENAL CORTEX HORMONES; BLEOMYCIN; CICATRIX, HYPERTROPHIC; GRAVITY SUITS; HUMANS; INJECTIONS, INTRALESIONAL; KELOID; SILICONE GELS; WOUND HEALING;

EID: 84906220104     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2014(08)11     Document Type: Review

References (97)

1. English RS, Shenefelt PD. Keloids and hypertrophic scars. Dermatol Surg. 1999;25(8):631-8, http://dx.doi.org/10.1046/j.1524-4725.1999.98257.x.
2. Atiyeh BS. Nonsurgical management of hypertrophic scars: evidencebased therapies, standard practices, and emerging methods. Aesthetic Plast Surg. 2007;31(5):468-92, http://dx.doi.org/10.1007/s00266-006-0253-y.
3. Anzarut A, Olson J, Singh P, Rowe BH, Tredget EE. The effectiveness of pressure garment therapy for the prevention of abnormal scarring after burn injury: a meta-analysis. J Plast Reconstr Aesthet Surg 2009;62:77-84, http://dx.doi.org/10.1016/j.bjps.2007.10.052.
4. Leventhal D, Furr M, Reiter D. Treatment of keloids and hypertrophic scars: a meta-analysis and review of the literature. Arch Facial Plast Surg. 2006;8(6):362-8.
5. Jalali M, Bayat A. Current use of steroids in management of abnormal raised skin scars. Surgeon. 2007;5(3):175-80, http://dx.doi.org/10.1016/ S1479-666X(07)80045-X.
6. Naeini FF, Najafian J, Ahmadpour K. Bleomycin tattooing as apromising therapeutic modality in large keloids and hypertrophicscars. Dermatol Surg. 2006;32(8):1023-9; discussion 1029-30, http://dx.doi.org/10.1111/j. 1524-4725.2006.32225.x.
7. Leclère FM, Mordon SR. Twenty-five years of active laser prevention of scars: what have we learned? J Cosmet Laser Ther 2010;12:227-34, http://dx.doi.org/10.3109/14764172.2010.514923.
8. OBrien L, Pandit A. Silicon gel sheeting for preventing and treating hypertrophic and keloid scars. Cochrane Database Syst Rev 2013;9: CD003826.
9. Shih R, Waltzman J, Evans GR. Plastic Surgery Educational Foundation Technology Assessment Committee Review of over-the-counter topical scar treatment products. Plast Reconstr Surg. 2007;119(3):1091-5, http:// dx.doi.org/10.1097/01.prs.0000255814.75012.35.
10. Ehrlich HP, Desmouliere A, Diegelmann RF, Cohen IK, Compton CC, Garner WL, et al. Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol. 1994;145(1):105-13.
11. Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG. Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies. Mol Med. 2011;17(1-2):113-25.
12. Al-Attar A, Mess S, Thomassen JM, Kauffman CL, Davison SP. Keloid pathogenesis and treatment. Plast Reconstr Surg. 2006;117:286-300, http://dx.doi.org/10.1097/01.prs.0000195073.73580.46.
13. Burd A, Huang L. Hypertrophic response and keloid diathesis: two very different forms of scar. Plast Reconstr Surg. 2005;116(7):150e-57e, http:// dx.doi.org/10.1097/01.prs.0000191977.51206.43.
14. Lane JE, Waller JL, Davis LS. Relationship between age of ear piercing and keloid formation. Pediatrics. 2005;115(5):1312-4, http://dx.doi.org/ 10.1542/peds.2004-1085.
15. Lee JY, Yang CC, Chao SC, Wong TW. Histopathological differential diagnosis of keloid and hypertrophic scar. Am J Dermatopathol. 2004;26(5):379-84.
16. Sabater-Marco V, Perez-Valles A, Berzal-Cantalejo F, Rodriguez-Serna M, Martinez-Diaz F, Martorell-Cebollada M. Sclerosing dermatofibrosarcoma protuberans (DFSP): an unusual variant with focus on the histopathologic differential diagnosis. Int J Dermatol. 2006;45:59-62.
17. DAndrea F, Vozza A, Brongo S, Di Girolamo F, Vozza G. Dermatofibrosarcoma protuberans: experience with 14 cases. J Eur Acad Dermatol Venereol. 2001;15(5):427-9, http://dx.doi.org/10.1046/j. 0926-9959.2001.00307.x.
18. Kanitakis J, Euvrard S, Sebbag L, Claudy A. Trichilemmal carcinoma of the skin mimicking a keloid in a heart transplant recipient. J Heart Lung Transplant. 2007;26(6):649-51, http://dx.doi.org/10.1016/j.healun.2007. 03.001.
19. Misago N, Ogusu Y, Narisawa Y. Keloidal basal cell carcinoma after radiation therapy. Eur J Dermatol. 2004;14(3):182-5.
20. Cannick L III, Douglas G, Crater S, Silver R. Nodular scleroderma: case report and literature review. J Rheumatol. 2003;30(11):2500-02.
21. Santiago M, de Castro DO Jr, Costa CA, Passos ES, Paixão A. Keloidal scleroderma. Clin Rheumatol. 2004;23(1):50-1.
22. Gonzalez-Vela MC, Val-Bernal JF, Gonzalez-Lopez MA, Drake M, Fernández-Llaca JH. Sclerotic neurofibroma: a neurofibroma mimicking sclerotic fibroma. J Cutan Pathol. 2006;33(1):47-50, http://dx.doi.org/10. 1111/j.0303-6987.2006.00392.x.
23. Verma R, Das AL, Vaishampayan SS, Vaidya S. Keloidal granuloma faciale with extrafacial lesions. Indian J Dermatol Venereol Leprol. 2005;71(5):345-7, http://dx.doi.org/10.4103/0378-6323.16787.
24. Krishnan RS, Hwang LY, Tschen JA, Subrt P, Hsu S. Erythema elevatum diutinum mimicking extensive keloids; quiz 386. Cutis. 2001;67(5):381-5.
25. Chirayil PT, Jayaraj J, Kumar P. Infantile digital fibromatosis-a case report. Burns. 2001;27(1):89-90, http://dx.doi.org/10.1016/S0305-4179 (00)00074-7.
26. Zelger BG, Sidoroff A, Zelger B. Combined dermatofibroma: co-existence of two or more variant patterns in a single lesion. Histopathology. 2002;36(6):529-39.
27. Bang RL. Penile oedema induced by continuous condom catheter use and mimicking keloid scar. Scand J Urol Nephrol. 1994;28(3):333-5.
28. Ibrahim RE, Sciotto CG, Weidner N. Pseudoangiomatous hyperplasia of mammary stroma. Some observations regarding its clinicopathologic spectrum. Cancer. 1989;63(6):1154-60.
29. Allan A, Andersen W, Rosenbaum M. Histologic features of lichen sclerosus et atrophicus in a surgical scar. Am J Dermatopathol. 1999;21(4):387-91.
30. Luz-Ramos M, Munoz-Perez MA, Pons A, Ortega M, Camacho F. Acne keloidalis nuchae and tufted hair folliculitis. Dermatology. 1997;194(1): 71-3.
31. Hecker MS, Weinberg JM. Cutaneous cryptococcosis mimicking keloid. Dermatology. 2001;202(1):78-9, http://dx.doi.org/10.1159/000051597.
32. Ogawa R, Akaishi S, Hyakusoku H. Differential and exclusive diagnosis of diseases that resemble keloids and hypertrophic scars. Ann Plast Surg. 2009;62(6):660-4, http://dx.doi.org/10.1097/SAP.0b013e31817e9d67.
33. Rockwell WB, Cohen IK, Ehrlich HP. Keloids and hypertrophic scars: a comprehensive review. Plast Reconstr Surg. 1989;84(5):827-37, http:// dx.doi.org/10.1097/00006534-198911000-00021.
34. Aarabi S, Longaker MT, Gurtner GC. Hypertrophic scar formation following burns and trauma: new approaches to treatment. PLoS Med. 2007;4(9):e234, http://dx.doi.org/10.1371/journal.pmed.0040234.
35. Bombaro KM, Engrav LH, Carrougher GJ, Wiechman SA, Faucher L, Costa BA, et al. What is the prevalence of hypertrophic scarring following burns? Burns. 2003;29(4):299-302, http://dx.doi.org/10.1016/ S0305-4179(03)00067-6.
36. Miller MC, Nanchahal J. Advances in the modulation of cutaneous wound healing and scarring. BioDrugs. 2005;19(6):363-81, http://dx.doi. org/10.2165/00063030-200519060-00004.
37. Tredget EE. Pathophysiology and treatment of fibroproliferative disorders following thermal injury. Ann N Y Acad Sci. 1999;888:165-82.
38. Wang J, Ding J, Jiao H, Honardoust D, Momtazi M, Shankowsky HA, et al. Human hypertrophic scar-like nude mouse model: characterization of the molecular and cellular biology of the scar process. Wound Repair Regen. 2011;19(2):274-85, http://dx.doi.org/10.1111/j.1524-475X.2011. 00672.x.
39. Honardoust D, Varkey M, Hori K, Ding J, Shankowsky HA, Tredget EE. Small leucine-rich proteoglycans, decorin and fibromodulin, are reduced in postburn hypertrophic scar. Wound Repair Regen. 2011;19(3):368-78, http://dx.doi.org/10.1111/j.1524-475X.2011.00677.x.
40. Scott PG, Dodd CM, Tredget EE, Ghahary A, Rahemtulla F. Immunohistochemical localization of the proteoglycans decorin, biglycan and versican and transforming growth factor-beta in human postburn hypertrophic and mature scars. Histopathology. 1995;26(5):423-31.
41. Shah M, Foreman DM, Ferguson MW. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci. 1995;108(Pt 3):985-1002.
42. Nedelec B, Shankowsky H, Scott PG, Ghahary A, Tredget EE. Myofibroblasts and apoptosis in human hypertrophic scars: the effect of interferon-alpha2b. Surgery. 2001;130(5):798-808, http://dx.doi.org/ 10.1067/msy.2001.116453.
43. Moulin V, Larochelle S, Langlois C, Thibault I, Lopez-Vallé CA, Roy M. Normal skin wound and hypertrophic scar myofibroblasts have differential responses to apoptotic inductors. J Cell Physiol. 2004;198(3):350-8, http://dx.doi.org/10.1002/jcp.10415.
44. Farina JA Jr, Freitas FA, Ungarelli LF, Rodrigues JM, Rossi LA. Absence of pathological scarring in the donor site of the scalp in burns: an analysis of 295 cases. Burns. 2010;36(6):883-90, http://dx.doi.org/10. 1016/j.burns.2009.11.015.
45. Forbes-Duchart L, Cooper J, Nedelec B, Ross L, Quanbury A. Burn therapists' opinion on the application and essential characteristics of a burn scar outcome measure. J Burn Care Res. 2009;30(5):792-800, http:// dx.doi.org/10.1097/BCR.0b013e3181b47cc2.
46. Biao Cheng, MD, PhD, Hong-Wei Liu, MD,{Xiao-Bing Fu. Update on pruritic mechanisms of hypertrophic scars in postburn patients: the potential role of opioids and their receptors. J of Burn Care & Res. 2011;32(4):e118-25.
47. Aarabi S, Bhatt KA, Shi Y, Paterno J, Chang EI, Loh SA, et al. Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis. FASEB J. 2007;21(12):3250-61, http://dx.doi.org/10.1096/fj. 07-8218com.
48. Jaad 2012: Tziotzios C, Profyris C, Sterling J. Cutaneous scarring: pathophysiology, molecular mechanisms and scar reduction therapeutics Part II. Strategies to reduce scar formation after dermatologic procedures. J Am Acad Dermatol. 2012;66(1):13-24.
49. Wang J, Hori K, Ding J, Huang Y, Kwan P, Ladak A, et al. Toll-like receptors expressed by dermal fibroblasts contribute to hypertrophic scarring. J Cell Physiol. 2011;226(5):1265-73, http://dx.doi.org/10.1002/ jcp.22454.
50. Mustoe TA, Cooter RD, Gold MH, Hobbs FD, Ramelet AA, Shakespeare PG, et al. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110(2):560-7, http://dx.doi.org/10.1097/ 00006534-200208000-00031.
51. Signorini M, Clementoni MT. Clinical evaluation of a new self-drying silicone gel in the treatment of scars: a preliminary report. Aesthetic Plast Surg. 2007;31(2):183-7, http://dx.doi.org/10.1007/s00266-005-0122-0.
52. Karagoz H, Yuksel F, Ulkur E, Evinc R. Comparison of efficacy of silicone gel, silicone gel sheeting, and topical onion extract including heparin and allantoin for the treatment of postburn hypertrophic scars. Burns. 2009;35(8):1097-103, http://dx.doi.org/10.1016/j.burns.2009.06. 206.
53. Gilman TH. Silicone sheet for treatment and prevention of hypertrophic scar: A new proposal for the mechanism of efficacy. Wound Rep Reg. 2003;11(3):235-6, http://dx.doi.org/10.1046/j.1524-475X.2003.11313.x.
54. Musgrave MA, Umraw N, Fish JS, Gomez M, Cartotto RC. The effect of silicone gel sheets on perfusion of hypertrophic burn scars. J Burn Care Rehab. 2002;23(3):208-14, http://dx.doi.org/10.1097/00004630-200205000-00010.
55. Niessen FB, Spauwen PH, Robinson PH, Fidler V, Kon M. The use of silicone occlusive sheeting (Sil-K) and silicone occlusive gel (Epiderm) in the prevention of hypertrophic scar formation. Plast Reconstr Surg. 1998;102(6):1962-72, http://dx.doi.org/10.1097/00006534-199811000-00023.
56. Hirshowitz B, Ullmann Y, Har-Shai Y, Vilenski A, Peled IJ. Silicone occlusive sheeting (SOS) in the management of hypertrophic scarring, including the possible mode of action of silicone, by static electricity. Eur J Plast Surg. 1993;16(1):5-9.
57. Har-Shai Y, Lindenbaum E, Tendler M, Gamliel-Lazarovich A, Feitelberg L, Hirshowitz B. Negatively charged static electricity stimulation as a possible mechanism for enhancing the involution of hypertrophic and keloid scars. Isr Med Assoc J. 1999;1(3):203-5.
58. Chan KY, Lau CL, Adeeb SM, Somasundaram S, Nasir-Zahari M. A randomized, placebo-controlled, double-blind, prospective clinical trial of silicone gel in prevention of hypertrophic scar development in median sternotomy wound. Plast Reconstr Surg. 2005;116(4):1013-20, http://dx. doi.org/10.1097/01.prs.0000178397.05852.ce.
59. Van den Kerckhove E, Stappaerts K, Boeckx W, Van den Hof B, Monstrey S, Van der Kelen A. Silicones in the rehabilitation of burns: A review and overview. Burns. 2001;27(3):205-14, http://dx.doi.org/10. 1016/S0305-4179(00)00102-9.
60. So K, Umraw N, Scott J, Campbell K, Musgrave M, Cartotto R. Effects of enhanced patient education on compliance with silicone gel sheeting and burn scar outcome: A randomized prospective study. J Burn Care Rehabil. 2003;24(6):411-7, http://dx.doi.org/10.1097/01.BCR.0000095516.98523.04.
61. Bloemen MCT, Van der Veer WM, Ulrich MW, van Zuijlen PP, Niessen FB, Middelkoop E. Prevention and curative management of hypertrophic scar formation. Burns. 2009;35(4):463-75, http://dx.doi.org/10.1016/ j.burns.2008.07.016.
62. Linares HA, Larson DL, Willis-Galstaun BA. Historical notes on the use of pressure in the treatment of hypertrophic scars or keloids. Burns. 1993;19(1):17-21, http://dx.doi.org/10.1016/0305-4179(93)90095-P.
63. Esselman PC, Thombs BD, Magyar-Russell G, Fauerbach JA. Burn rehabilitation: State of the science. Am J Phys Med Rehabil. 2006;85(4): 383-413, http://dx.doi.org/10.1097/01.phm.0000202095.51037.a3.
64. Macintyre L, Baird M. Pressure garments for use in the treatment of hypertrophic scars: A review of the problems associated with their use. Burns. 2006;32(1):10-5, http://dx.doi.org/10.1016/j.burns.2004.06.018.
65. Puzey G. The use of pressure garments on hypertrophic scars. J Tissue Viability. 2002;12(1):11-5.
66. Costa AM, Peyrol S, Porto LC, Comparin JP, Foyatier JL, Desmouliere A. Mechanical forces induce scar remodeling. Study in non-pressuretreated versus pressure-treated hypertrophic scars. Am J Pathol. 1999; 155(5):1671-9.
67. Reno F, Sabbatini M, Lombardi F, Stella M, Pezzuto C, Magliacani G, et al. In vitro mechanical compression induces apoptosis and regulates cytokines release in hypertrophic scars. Wound Rep Reg. 2003;11(5):331-6, http://dx. doi.org/10.1046/j.1524-475X.2003.11504.x.
68. Reno F, Sabbatini M, Stella M, Magliacani G, Cannas M. Effect of in vitro mechanical compression on Epilysin (matrix metalloproteinase-28) expression in hypertrophic scars. Wound Repair Regen. 2005;13(3): 255-61, http://dx.doi.org/10.1111/j.1067-1927.2005.130307.x.
69. Engrav LH, Heimbach DM, Rivara FP, Moore ML, Wang J, Carrougher GJ, et al. 12-Year within-wound study of the effectiveness of custom pressure garment therapy. Burns. 2010;36(7)975-83, http://dx.doi.org/ 10.1016/j.burns.2010.04.014.
70. Van den Kerckhove E, Stappaerts K, Fieuws S, Laperre J, Massage P, Flour M. The assessment of erythema and thickness on burn related scars during pressure garment therapy as a preventive measure for hypertrophic scarring. Burns. 2005;31(6):696-702, http://dx.doi.org/10.1016/ j.burns.2005.04.014.
71. Cho JW, Cho SY, Lee SR, Lee KS. Onion extract and quercetin induce matrix metalloproteinase-1 in vitro and in vivo. Int J of Mol Med. 2010;25(3):347-52.
72. Ho WS, Ying SY, Chan PC, Chan HH. Use of onion extract, heparin, allantoin gel in prevention of scarring in Chinese patients having laser removal of tattoos: A prospective randomized controlled trial. Dermatol Surg. 2006;32(7):891-6, http://dx.doi.org/10.1111/j.1524-4725.2006.32192.x.
73. Koc E, Arca E, Surucu B, Kurumlu Z. An open, randomized, controlled, comparative study of the effect of intralesional triamcinolone acetonide and onion extract gel and intralesional triamcinolone acetonide alone in the treatment of hypertrophic scars and keloids. Dermatol Surg. 2008;34(11):1507-14, http://dx.doi.org/10.1111/j.1524-4725.2008.34314.x.
74. Willital GH, Heine H. Efficacy of contractubex gel in the treatment of fresh scars after thoracic surgery in children and adolescents. Int J Clin Pharm Res. 1994;14(5-6):193-202.
75. Chanprapaph K, Tanrattanakorn S, Wattanakrai P, Wongkitisophon P, Vachiramon V. Effectiveness of onion extract gel on surgical scars in Asians. Dermatol Res Pract. 2012;2012:212945.
76. Chen MA, Davidson TM. Scar management: Prevention and treatment strategies. Curr Opinion Otolaryngol Head Neck Surg. 2005;13(4):242-7, http://dx.doi.org/10.1097/01.moo.0000170525.74264.f8.
77. Niessen FB, Spauwen P, Schalkwijk J, Kon M. On the nature of hypertrophic scars and keloids: A review. Plast Reconstr Surg. 1999;104(5):1435-58, http://dx.doi.org/10.1097/00006534-199910000-00031.
78. Manuskiatti W, Fitzpatrick RE. Treatment response of keloidal and hypertrophic sternotomy scars: Comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments. Arch Dermatol. 2002;138(9):1149-55, http://dx.doi.org/ 10.1001/archderm.138.9.1149.
79. Roques C., Téot L. The use of corticoids to treat keloids: A review. Int J of Low Extrem Wounds. 2008;7(3):137-45, http://dx.doi.org/10.1177/ 1534734608320786.
80. George WM. Linear lymphatic hypopigmentation after intralesional corticosteroid injection: Report of two cases. Cutis. 1999;64(1):61-4.
81. Bodokh I, P Brun. Traitement des chéloïdes par infiltrations de bléomycine. Ann Dermatol Venereol. 1996;123(12):791-4.
82. Bennett JM., Reich SD. Bleomycin. Ann Intern Med. 1979;90(6):945-8, http://dx.doi.org/10.7326/0003-4819-90-6-945.
83. Espana A, Solano T, Quintanilla E. Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures. Dermatol Surg. 2001;27(1):23-7, http://dx.doi.org/10.1111/j.1524-4725.2001.99315.x.
84. Templeton SF, Solomon AR, Swerlick RA. Intradermal bleomycin injections into normal human skin. A histopathologic and immunopathologic study. Arch Dermatol. 1994;130(5):577-83, http://dx.doi.org/ 10.1001/archderm.1994.01690050045006.
85. James MP, Collier PM, Aherne W, Hardcastle A, Lovegrove S. Histologic, pharmacologic, and immunocytochemical effects of injection of bleomycin into viral warts. J Am Acad Dermatol. 1993;28(6):933-7, http://dx. doi.org/10.1016/0190-9622(93)70133-E.
86. Saray Y, Gulec AT. Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: a preliminary study. Int J Dermatol. 2005;44:777-84.
87. Crooke ST, Bradner WT. Bleomycin, a review. J Med. 1976;7(5):333-428.
88. Shridharani SM, Magarakis M, Manson PN, Singh NK, Basak B, Rosson GD. The emerging role of antineoplastic agents in the treatment of keloids and hypertrophic scars. Annals of Plastic Surgery. 2010;64(3): 355-61, http://dx.doi.org/10.1097/SAP.0b013e3181afaab0.
89. Kelly AP. Medical and surgical therapies for keloids. DermatolTher. 2004;17(2):212-8.
90. Zoubollis CC, Blume U, Büttner P, Orfanos CE. Outcomes of cryosurgery in keloids and hypertrophic scars: a prospective consecutive trial of case series. Arch Dermatol. 1993;129(9):1146-51.
91. Freshwater MF. Botulinum toxin for scars: can it work, does it work, is it worth it? J Plast Reconstr Aesthet Surg. 2013;66(3):e92-3, http://dx.doi. org/10.1016/j.bjps.2012.11.034.
92. Romero-Valdovinos M, Cárdenas-Mejía A, Gutiérrez-Gómez C, Flisser A, Kawa-Karasik S, Ortiz-Monasterio F. Keloid skin scars: the influence of hyperbaric oxygenation on fibroblast growth and on the expression of messenger RNA for insulin like growth factor and for transforming growth factor. In Vitro Cell Dev Biol Anim. 2011;47(7):421-4, http://dx. doi.org/10.1007/s11626-011-9418-3
93. Carvalho GF, Silva RMV, Mesquita-Filho Joaquim JT, Meyer PF, Ronzio OA, Medeiros JO, et al. Avaliação dos efeitos da radiofrequência no tecido. RBM-Rev Bras Med. Edição Especial Dermatologia&Cosmiatria 2011;68:10-25.
94. Hudson DA, Renshaw A. An algorithm for the release of burn contractures of the extremities. Burns. 2006;32(6):663-8, http://dx.doi. org/10.1016/j.burns.2006.02.009.
95. Aldunate JLCB, Fontana LPMVC, Ferreira MC. Use of dermal matrix and negative pressure dressings for the treatment of contractures in burn patients. Rev Bras Cir Plást. 2012;27(3):369-73, http://dx.doi.org/10. 1590/S1983-51752012000300006.
96. Silva MMA, Furtado FMGP, Hochman B, Ferreira ML. Recidiva de quelóides: o estresse psicológico como fator de risco. Rev Bras Cir Plást. 2012;27(supl):1-102.
97. Jaimovich CA, Neto MK, Almeida AHT, Pinheiro AG, Loma DC. Consentimento informado e cirurgia plástica. Rev Bras Cir Plást. 2007;22(3):188-93.